JULIO EDUARDO
NUÑEZ VILLOTA

2024

1. Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI

   Journal of the American College of Cardiology, Vol. 83, Núm. 9, pp. 904-914

2. Baseline resting heart rate and responsiveness to a home-based inspiratory muscle training program in long COVID

   Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 344-347

3. C-reactive protein in patients with acute heart failure and preserved ejection fraction

   Revista Espanola de Cardiologia, Vol. 77, Núm. 5, pp. 430-433

4. Carbohydrate antigen 125-guided pre-TAVI medical optimization: impact on quality of life and clinical outcomes

   Revista Espanola de Cardiologia

5. Circulating levels of carbohydrate antigen 125 in chronic heart failure: Useful or futile?

   European Journal of Heart Failure

6. Combinational Diuretics in Heart Failure

   Current Heart Failure Reports

7. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

   European Journal of Internal Medicine

8. Consensus document on the management of hyperkalemia

   Nefrologia

9. Consensus on the Approach to Hydrosaline Overload in Acute Heart Failure. SEMI/SEC/S.E.N. Recommendations

   Revista Espanola de Cardiologia

10. Correction to: Diagnosis of heart failure with preserved ejection fraction: a systematic narrative review of the evidence (Heart Failure Reviews, (2023), 29, 1, (179-189), 10.1007/s10741-023-10360-z)

    Heart Failure Reviews

11. Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure

    ESC Heart Failure, Vol. 11, Núm. 3, pp. 1767-1776

12. Diagnosis of heart failure with preserved ejection fraction: a systematic narrative review of the evidence

    Heart Failure Reviews, Vol. 29, Núm. 1, pp. 179-189

13. Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC

    European Journal of Heart Failure

14. Differential sex-related effect of left ventricular ejection fraction trajectory on the risk of mortality and heart failure readmission following hospitalization for acute heart failure: A longitudinal study

    European Journal of Heart Failure

15. Effect of SGLT2 inhibitors on anemia and their possible clinical implications

    Nefrologia , Vol. 44, Núm. 2, pp. 165-172

16. Effect of paced heart rate on quality of life and natriuretic peptides for stage B or C heart failure with preserved ejection fraction: A secondary analysis of the myPACE trial

    European Journal of Heart Failure, Vol. 26, Núm. 1, pp. 167-176

17. Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING-HF trial

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 15, Núm. 2, pp. 681-689

18. Heart failure with preserved ejection fraction: Do we identify phenotypes or individualise the assessment?

    Revista Espanola de Geriatria y Gerontologia, Vol. 59, Núm. 3

19. Histopathology of congestive nephropathy: a case description and literature review

    ESC Heart Failure

20. Impact of Epicardial Adipose Tissue on Infarct Size and Left Ventricular Systolic Function in Patients with Anterior ST-Segment Elevation Myocardial Infarction

    Diagnostics, Vol. 14, Núm. 4